# National Surgical Adjuvant Study of Breast Cancer(N-SAS BC) 07 [RESPECT]

> **NCT01104935** · PHASE3 · COMPLETED · sponsor: **Comprehensive Support Project for Oncology Research** · enrollment: 275 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** trastuzumab monotherapy
- **DRUG:** trastuzumab and chemotherapy

## Key facts

- **NCT ID:** NCT01104935
- **Lead sponsor:** Comprehensive Support Project for Oncology Research
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-10-28
- **Primary completion:** 2017-10-31
- **Final completion:** 2018-10-15
- **Target enrollment:** 275 (ACTUAL)
- **Last updated:** 2019-10-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01104935

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01104935, "National Surgical Adjuvant Study of Breast Cancer(N-SAS BC) 07 [RESPECT]". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01104935. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*